WADA prohibited list comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-05-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Status varies by country; prohibited in sport. |
| Common storage temperature | 2–8 °C for lyophilized powder | Protect from light and moisture; follow supplier instructions. |
| Typical analytical method | LC-MS/MS | Used for identification and quantification in biological samples. |
| Purity assessment | HPLC and mass spectrometry | Reverse-phase HPLC is common for peptide purity. |
| Common synonyms | AOD9604; hGH 176-191 fragment | Naming conventions differ across studies. |
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
=== Associated defects/diseases === There are thousands of deaths a year of infants, either during or shortly after birth, and the leading cause of these deaths are congenital birth defects (CBDs), which are defined as abnormalities of the chromosomes. In the year 2004, CBDs had been the cause of over 139,000 hospitalizations in the U.S. and had cost the community $2.6 billion in healthcare and medical supplies. While some CBDs can be easily fixed by simple surgery or medication, such as cleft lip, there are still life threatening diseases that are caused by mutations to the Grhl family members or genetic pathways that they are associated with. In developing countries, where there is a large percentage of the population in poverty, families struggle to receive the necessary treatment to combat CBDs and the extent at which the quality of life is affected is continually worsening. Members of the Grhl3 family are closely related to endodermal tissues and the issues that can arise from a mutation in one of the Grhl family members can include respiratory problems, loss of hearing, spina bifida and much more. Grhl3 has been shown to be a downstream target of genes such as Fgf8 and Irf6, of which the associated pathways are involved in the aetiology of Van der Woude syndrome.
under the joint auspices of the George Washington University and the Carnegie Institution of Washington. There, the news on nuclear fission was spread even further, which fostered many more experimental demonstrations. The 6 January 1939 Hahn and Strassman paper announced the discovery of fission. In their second publication on nuclear fission in February 1939, Hahn and Strassmann used the term Uranspaltung (uranium fission) for the first time, and predicted the existence and liberation of additional neutrons during the fission process, opening up the possibility of a nuclear chain reaction. The 11 February 1939 paper by Meitner and Frisch compared the process to the division of a liquid drop and estimated the energy released at 200 MeV. The 1 September 1939 paper by Bohr and Wheeler used this liquid drop model to quantify fission details, including the energy released, estimated the cross section for neutron-induced fission, and deduced 235U was the major contributor to that cross section and slow-neutron fission.
Allergen immunotherapy is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an effort to change the immune system's response. Meta-analyses have found that injections of allergens under the skin is effective in the treatment in allergic rhinitis in children and in asthma. The benefits may last for years after treatment is stopped. It is generally safe and effective for allergic rhinitis and conjunctivitis, allergic forms of asthma, and stinging insects. To a lesser extent, the evidence also supports the use of sublingual immunotherapy for rhinitis and asthma. For seasonal allergies the benefit is small. In this form the allergen is given under the tongue and people often prefer it to injections. Immunotherapy is not recommended as a stand-alone treatment for asthma.
Modern definitions are concerned with the fundamental chemical reactions common to all acids. Most acids encountered in everyday life are aqueous solutions, or can be dissolved in water, so the Arrhenius and Brønsted–Lowry definitions are the most relevant. The Brønsted–Lowry definition is the most widely used definition; unless otherwise specified, acid–base reactions are assumed to involve the transfer of a proton (H+) from an acid to a base. Hydronium ions are acids according to all three definitions. Although alcohols and amines can be Brønsted–Lowry acids, they can also function as Lewis bases due to the lone pairs of electrons on their oxygen and nitrogen atoms.
Lead (82Pb) has four observationally stable isotopes: 204Pb, 206Pb, 207Pb, 208Pb. Lead-204 is entirely a primordial nuclide and is not a radiogenic nuclide. The three isotopes lead-206, lead-207, and lead-208 represent the ends of three decay chains: the uranium series (or radium series), the actinium series, and the thorium series, respectively; a fourth decay chain, the neptunium series, terminates with the thallium isotope 205Tl. The three series terminating in lead represent the decay chain products of long-lived primordial 238U, 235U, and 232Th. Each isotope also occurs, to some extent, as primordial isotopes that were made in supernovae, rather than radiogenically as daughter products. The fixed ratio of lead-204 to the primordial amounts of the other lead isotopes may be used as the baseline to estimate the extra amounts of radiogenic lead present in rocks as a result of decay from uranium and thorium. This is the basis for lead–lead dating and uranium–lead dating. The longest-lived radioisotopes, both decaying by electron capture, are 205Pb with a half-life of 17.0 million years and 202Pb with a half-life of 52,500 years. A shorter-lived naturally occurring radioisotope, 210Pb with a half-life of 22.2 years, is useful for studying the sedimentation chronology of environmental samples on time scales shorter than 100 years. The heaviest stable isotope, 208Pb, belongs to this element. (The more massive 209Bi, long considered to be stable, actually has a half-life of 2.01×1019 years.) 208Pb is also a doubly magic isotope, as it has 82 protons and 126 neutrons.
Sources: en.wikipedia.org
=== Prandial insulin === When a person eats food containing carbohydrates and glucose, insulin helps regulate the body's metabolism of the food. Prandial insulin, also called mealtime or bolus insulin, is designed as a bolus dose of insulin prior to a meal to regulate the spike in blood glucose that occurs following a meal. The dose of prandial insulin may be static, or may be calculated by the patient using either their current blood sugar, planned carbohydrate intake, or both. This calculation may also be performed by an insulin pump in patients using a pump. Insulin regiments that consist of doses calculated in this manner are considered intensive insulin regimens. Prandial insulin is usually administered no more than 15–30 minutes prior to a meal using a rapid-acting insulin or a regular insulin. In some patients, a combination insulin may be used that contains both NPH (long acting) insulin and a rapid/regular insulin to provide both a basal insulin and prandial insulin.
==== 2009 ==== In January 2009, Krasnaya Zvezda published an interview with Father Mikhail, the Orthodox priest, who said: "I attended military exercise "Kavkaz-2008" in South Ossetia, where our paratroopers worked out the skills of combat in the mountains. Unfortunately, those skills became useful too soon..." In late January 2009, Russian sergeant Aleksandr Glukhov ran away from Akhalgori District and requested a political asylum in Tbilisi. He had served in the 693rd regiment and he declared that he was deployed to South Ossetia in July 2008. In May 2009, Rossiyskaya Gazeta reported that hero of Russia, Denis Vetchinov, who died in South Ossetia, left the base of the Motor Rifle Division in Vladikavkaz for Tskhinvali on the early morning of 7 August 2008. In June 2009, Russian General Vyacheslav Borisov told Echo of Moscow in an interview: "I headed the South Ossetian and the Georgian directions. You know, we even regularly hold exercises in those areas. And our troops had full practice by holding exercises one week before right there in the same place. And we had only concluded and went." In July 2009, Russian journalist Ella Polyakova wrote that some Russian soldiers had told her that they arrived in South Ossetia on 4 August 2008, while their records claimed that they were stationed in North Ossetia. In July 2009, Russian blogger published an interview with soldier Maksim Belyaev, who said: "Our combined battalion of peacekeepers was stationed in North Ossetia. We should have replaced in August another battalion of the peacekeeping mission, located in Tskhinvali.
===== Doctor of Pharmacy (PharmD) ===== The Doctor of Pharmacy Degree is the only entry-level professional degree offered by the college. The program is fully accredited by the Accreditation Council for Pharmacy Education. Graduates are eligible to sit for the North American Pharmacist Licensure Examination (NAPLEX). Approximately 97 students are enrolled into each class. The Doctor of Pharmacy curriculum is divided into the following:
== Side effects == U-47700 has never been studied in humans, but it would be expected to produce effects similar to those of other potent opioid agonists, including strong analgesia, sedation, euphoria, constipation, itching and respiratory depression which could be harmful or fatal. Tachycardia was another side effect encountered with U-47700 use. Tolerance and dependence would be expected to develop.
A refrigerated container or reefer is an intermodal container (shipping container) used in intermodal freight transport that is capable of refrigeration for the transportation of temperature-sensitive, perishable cargo. These containers are a critical component of the cold chain, the supply chain that preserves goods like fruits, vegetables, meat, and pharmaceuticals at a specific low temperature. While a reefer has an integral refrigeration unit, it relies on external power from electrical power points (“reefer points”) at a land-based site, a container ship, or on a quay. When being transported over the road on a trailer or over a rail wagon, it can be powered from a diesel-powered generator ("gen set") that attaches to the container during road journeys. Refrigerated containers are capable of maintaining a constant internal temperature ranging from −65 °C (−85 °F) up to 40 °C (104 °F). The market for cold chain tracking solutions is growing rapidly, driven by the increasing global demand for fresh food and temperature-sensitive pharmaceuticals. The number of active tracking devices for refrigerated containers is projected to grow significantly, highlighting the increasing importance of this technology for ensuring food safety and product integrity. The impact on society of reefer containers is vast, allowing consumers all over the world to enjoy fresh produce at any time of year.
Sources: en.wikipedia.org
Dried timber is lighter, and the transportation and handling costs are reduced. Dried timber is stronger than green timber in most strength properties. Timbers for impregnation with preservatives have to be properly dried if proper penetration is to be accomplished, particularly in the case of oil-type preservatives. In the field of chemical modification of wood and wood products, the material should be dried to a certain moisture content for the appropriate reactions to occur. Dry wood generally works, machines, finishes and glues better than green timber (although there are exceptions; for instance, green wood is often easier to turn than dry wood). Paints and finishes last longer on dry timber. The electrical and thermal insulation properties of wood are improved by drying. Prompt drying of wood immediately after felling therefore significantly upgrades and adds value to raw timber. Drying enables substantial long-term economy by rationalizing the use of timber resources. The drying of wood is thus an area for research and development, which concern many researchers and timber companies around the world.
During the COVID-19 pandemic, many jurisdictions around the world introduced biosecurity measures at internal borders. This ranged from quarantine measures imposed upon individuals crossing state lines within America to prohibitions on interstate travel in Australia.
phagocyte Any cell capable of phagocytosis, especially any of various cell types of the immune system which engulf and ingest harmful foreign molecules, bacteria, and dead or dying cells, including neutrophils and macrophages.
The magnetic field in a solar active region above a sunspot can store energy that is suddenly released as a burst of motion, X-rays, and radiation when the main current sheet collapses and reconnects the field.
For about four days immediately prior to egg-laying, when copulations lead to fertilization, the male bank swallow is very busy, attentively guarding his female. Before this time, as well as after—that is, when her eggs are not ripe, and again after his genes are safely tucked away inside the shells—he goes seeking extra-pair copulations with the mates of other males…who, of course, are busy with defensive mate-guarding of their own.
Sources: en.wikipedia.org
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.
The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.
Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.